Biodexa Pharmaceuticals (BDRX)
4.16
-0.08 (-1.89%)
At close: Jan 15, 2025, 11:24 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -7.08M | -7.66M | -5.46M | -22.19M | -10.09M | -15.03M | -16.06M | -20.16M | -10.10M | -8.82M | -4.08M | -3.99M |
| Depreciation & Amortization | 283.00K | 343.00K | 403.00K | 1.22M | 1.28M | 1.11M | 1.17M | 4.35M | 736.00K | 321.00K | 246.00K | 194.00K |
| Stock-Based Compensation | 28.00K | 123.00K | 89.00K | -404.00K | -34.00K | n/a | n/a | n/a | 170.00K | n/a | n/a | n/a |
| Other Working Capital | -414.00K | 513.00K | -130.00K | -2.05M | 1.07M | 165.00K | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Non-Cash Items | 397.00K | 454.00K | -892.00K | 430.00K | 2.33M | -1.07M | 3.11M | 3.21M | -1.63M | 2.29M | -156.00K | 584.00K |
| Deferred Income Tax | -406.00K | -832.00K | 469.00K | 13.20M | -1.78M | n/a | n/a | n/a | 1.43M | n/a | n/a | n/a |
| Change in Working Capital | -49.00K | 520.00K | -617.00K | -1.56M | 1.80M | 1.54M | -1.17M | -479.00K | -1.60M | 761.00K | -442.00K | -169.00K |
| Operating Cash Flow | -6.83M | -7.05M | -6.01M | -9.30M | -6.49M | -13.45M | -12.95M | -13.09M | -12.42M | -5.46M | -4.44M | -3.22M |
| Capital Expenditures | -263.00K | -62.00K | -320.00K | -209.00K | -319.00K | -244.00K | -707.00K | -1.35M | -922.00K | -1.03M | -47.00K | -239.00K |
| Acquisitions | n/a | n/a | n/a | n/a | -947.00K | n/a | n/a | n/a | -661.00K | 115.00K | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | -2.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | 2.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -239.00K | -158.00K | 42.00K | 144.00K | -939.00K | 9.29M | -763.00K | 145.00K | 50.00K | 8.00K | -3.00K | -59.00K |
| Investing Cash Flow | -265.00K | -220.00K | -278.00K | 2.57M | -3.81M | 9.04M | -1.47M | -1.20M | -1.53M | -907.00K | -50.00K | -298.00K |
| Debt Repayment | -188.00K | -178.00K | -215.00K | -6.18M | 3.86M | -5.88M | 4.68M | -239.00K | -214.00K | 544.00K | 1.05M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -13.00K | -18.00K | -15.00K | -476.00K | 766.00K | -587.00K | -136.00K | 15.49M | -5.00K | -96.00K | -108.00K | -125.00K |
| Financial Cash Flow | 10.23M | 47.00K | 8.80M | 3.08M | 18.73M | -6.47M | 10.28M | 15.26M | -219.00K | 34.30M | 6.74M | -125.00K |
| Net Cash Flow | 3.13M | -7.22M | 2.51M | -3.38M | 8.59M | -10.86M | -4.40M | 1.43M | -14.15M | 27.94M | 2.25M | 133.00K |
| Free Cash Flow | -7.09M | -7.11M | -6.33M | -9.51M | -6.81M | -13.69M | -13.66M | -14.43M | -13.34M | -6.49M | -4.48M | -3.46M |